- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.11. | Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue | 1 | Investing.com | ||
| 06.11. | Quartalsbericht: Treace Medical Concepts verzeichnet 11% Umsatzsteigerung im dritten Quartal | 1 | Investing.com Deutsch | ||
| 05.11. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Third Quarter 2024 Financial Results | 52 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 05.11. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 05.11. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | Earnings Preview For Treace Medical Concepts | 2 | Benzinga.com | ||
| 22.10. | Treace Medical Concepts, Inc.: Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 | 2 | GlobeNewswire (USA) | ||
| 15.10. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| 14.10. | Treace Medical Concepts, Inc.: Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology | 1 | GlobeNewswire (USA) | ||
| 18.09. | Treace Medical Concepts (TMCI) Slid on Reduced Guidance | 2 | Insider Monkey | ||
| 17.09. | Treace Medical Concepts CEO buys $265k worth of company stock | 2 | Investing.com | ||
| 11.09. | Treace Medical Concepts, Inc.: Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024 | 85 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 22.08. | Treace Medical Concepts, Inc.: Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| 07.08. | Earnings call: Treace Medical sees steady growth and plans new products | 2 | Investing.com | ||
| 18.07. | Treace Medical Concepts, Inc.: Treace to Report Second Quarter 2024 Financial Results on August 6, 2024 | 1 | GlobeNewswire (USA) | ||
| 16.07. | Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock | 1 | Benzinga.com | ||
| 28.05. | Treace Medical Concepts, Inc.: Treace to Present at Truist Securities MedTech Conference | 3 | GlobeNewswire (USA) | ||
| 08.05. | Pre-market Movers: Treace Medical Concepts, DoubleVerify, Neo-Concept International, ZoomInfo Technologies, Innodata | 640 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.50 A.M. ET).In the Green Neo-Concept International Group Holdings Limited... ► Artikel lesen | |
| 27.02. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance | 224 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 08.01. | Treace Medical Concepts, Inc.: Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue | 355 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,070 | 0,00 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
| BIOMERICA | 0,320 | 0,00 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
| LIFEMD | 5,400 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| PROPHASE LABS | 0,690 | +0,73 % | ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript |
Das Unternehmen TREACE MEDICAL CONCEPTS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 7,960 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TREACE MEDICAL CONCEPTS INC finden Sie auf Wallstreet Online.
